Truist Securities Reiterates Buy on HCA Healthcare, Raises Price Target to $510
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsReiterationPrice TargetHot
Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.
Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.